168 related articles for article (PubMed ID: 1674363)
1. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of pirenzepine and ranitidine on the nocturnal intragastric pH in non-responders to ranitidine.
Walker S; Klotz U; Bode JC
Z Gastroenterol; 1990 Aug; 28(8):379-82. PubMed ID: 2275257
[TBL] [Abstract][Full Text] [Related]
3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
4. [The effects of nizatidine and misoprostol on peptic activity and gastric mucus].
Grassi SA; Vianello F; Germanà B; Dal Santo P; Faggian D; Battaglia G; Plebani M; Di Mario F; Naccarato R
Medicina (Firenze); 1990; 10(1):29-31. PubMed ID: 1974318
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Thomson AB; Mahachai V
Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
[TBL] [Abstract][Full Text] [Related]
6. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Walker S; Krishna DR; Klotz U; Bode JC
Gut; 1989 Aug; 30(8):1105-9. PubMed ID: 2570008
[TBL] [Abstract][Full Text] [Related]
7. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Vakhrushev IaM; Loshchakova OIu
Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
[TBL] [Abstract][Full Text] [Related]
8. [Drug therapy of peptic ulcer. What is coming up?].
Müller P; Dammann HG; Simon B; Kommerell B
Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
[TBL] [Abstract][Full Text] [Related]
9. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
Karateev AE; Murav'ev IuV; Nasonova VA
Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
[TBL] [Abstract][Full Text] [Related]
10. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
11. Anti-ulcer drugs in antisecretory doses for "cytoprotection" in arthritic patients?
Londong W
Klin Wochenschr; 1986; 64 Suppl 7():32-4. PubMed ID: 2882050
[TBL] [Abstract][Full Text] [Related]
12. Controlling gastric pH: the impact of newer agents on the critically ill patient.
Earnest DL
DICP; 1990 Nov; 24(11 Suppl):S31-4. PubMed ID: 1980181
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
14. Prevention of NSAID-induced GI mucosal injury.
Gerritz S; Newton WP
J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
[No Abstract] [Full Text] [Related]
15. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
Thomson AB
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of stress ulcer in intensive care patients].
Laggner AN; Lenz K
Wien Med Wochenschr; 1986 Nov; 136(21-22):596-9. PubMed ID: 2881401
[TBL] [Abstract][Full Text] [Related]
17. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring.
Savarino V; Scalabrini P; Mela GS; di Timoteo E; Percario G; Magnolia MR; Celle G
Dig Dis Sci; 1988 Mar; 33(3):293-7. PubMed ID: 3125025
[TBL] [Abstract][Full Text] [Related]
19. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
20. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
